Silo Pharma, Inc. — Investor Relations & Filings
Silo Pharma, Inc. is a developmental-stage biopharmaceutical company focused on developing novel therapeutics for underserved medical conditions by merging traditional pharmaceuticals with psychedelic research. The company's portfolio targets a range of indications, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. Key development programs include SPC-15 for post-traumatic stress disorder (PTSD) and SP-26 for fibromyalgia, alongside preclinical assets for Alzheimer's disease and multiple sclerosis. Silo Pharma utilizes the 505(b)(2) regulatory pathway for certain licensed therapeutics to potentially streamline the approval process. The company conducts its research through collaborations with universities and laboratories to build its intellectual property portfolio.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Director's Dealing 2024 | 2024-12-16 | English | |
| Director's Dealing 2024 | 2024-11-22 | English | |
| PROXY STATEMENT | 2024-11-15 | English | |
| Major Shareholding Notification 2024 | 2024-11-13 | English | |
| QUARTERLY REPORT | 2024-11-12 | English | |
| CURRENT REPORT | 2024-11-08 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 12428988 | Director's Dealing 2024 | 2024-12-16 | English | ||
| 12428993 | Director's Dealing 2024 | 2024-11-22 | English | ||
| 12428995 | PROXY STATEMENT | 2024-11-15 | English | ||
| 12428996 | Major Shareholding Notification 2024 | 2024-11-13 | English | ||
| 12429002 | QUARTERLY REPORT | 2024-11-12 | English | ||
| 12429004 | CURRENT REPORT | 2024-11-08 | English | ||
| 12429007 | CURRENT REPORT | 2024-11-08 | English | ||
| 12429010 | ANNUAL REPORT | 2024-09-18 | English | ||
| 12429012 | ADDITIONAL DEFINITIVE SOLICITING MATERIALS. | 2024-09-18 | English | ||
| 12429013 | PROXY STATEMENT | 2024-09-18 | English | ||
| 12429018 | CURRENT REPORT | 2024-09-10 | English | ||
| 12429021 | PROSPECTUS | 2024-09-04 | English | ||
| 12429022 | Regulatory Filings 2024 | 2024-09-04 | English | ||
| 12429023 | Regulatory Filings 2024 | 2024-08-29 | English | ||
| 12429024 | Regulatory Filings 2024 | 2024-08-28 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Silo Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35304/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35304 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35304 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35304 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35304}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Silo Pharma, Inc. (id: 35304)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.